• Accutane(4 Articles)
  • Avandia(1 Articles)
  • other(5 Articles)
  • Latest News from Pharma-Watch

    FDA convenes to determine Fosamax bone fracture dangers

    The New York Times Reports: In light of evidence linking the long-term use of Fosamax and femur fractures, the FDA said it plans to convene Friday to determine whether it will recommend suspending the use of the osteoporosis drug.

    Spine Specialists Discredit Medtronic Bone Growth Product

    June 29th, 2011 “It harms patients to have biased and corrupted research published…It harms patients to have unaccountable special interests permeate medical research,” read an excerpt from an

    CT Brain Perfusion Scan Risks

    The FDA released an advisory to consumers in October regarding the CT Bran Profusion Scan manufactured by GE. The advisory states that the scans default radiation therapy is set to high for most patient

    Risk of death found in sleeping pill use -- Scripps

    Scripps Study: Sleeping pills believed a cause of 500,000 premature deaths annually (March 1, 2012) Pick 10 people at random and ask them if they take sleeping pills. Chances are at least one of them

    FDA pulls approval of Avastin breast cancer drug

    Avastin no longer allowed for breast cancer The U.S. Food & Drug Administration has revoked its approval of Avastin after concluding the metastatic breast cancer treatment did nothing to control tumor